Insider · CIK 0001906496
Manish Sarin
cfoofficer
Files at CXM (Sprinklr, Inc.). First filing Dec 18, 2024, latest Jun 18, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $971k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CXM: Sprinklr, Inc.
CXMOct 9, 2026 · close 5.52
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | Sprinklr, Inc. | $292k 35,744 shares | -4% | +19% from low-13% from high | |
| 53Moderate | Sprinklr, Inc. | $425k 48,068 shares | -5% | +24% from low-8% from high | |
| 50Moderate | Sprinklr, Inc. | $254k 27,118 shares | -4% | +35% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | CXM Sprinklr, Inc. | SOpen-market sale Class A Common Stock | -35,744 | $8.17 | $292k | 932,238 | Jun 18, 2025 |
| Mar 17, 2025 | CXM Sprinklr, Inc. | SOpen-market sale Class A Common Stock | -48,068 | $8.84 | $425k | 967,982 | Apr 21, 2025 |
| Dec 16, 2024 | CXM Sprinklr, Inc. | SOpen-market sale Class A Common Stock | -26,890 | $9.37 | $252k | 716,278 | Dec 18, 2024 |
| Dec 17, 2024 | CXM Sprinklr, Inc. | SOpen-market sale Class A Common Stock | -228 | $9.32 | $2,125 | 716,050 | Dec 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.